Effectiveness and Tolerability of Vildagliptin plus Metformin Dual Therapy Compared with Insulin Secretagogue plus Metformin Dual Therapy in Patients with Type 2 Diabetes-A Real-World Study (China PDS)

被引：0
|
作者：
Chen, Lixian
Han, Ying
Hu, Daqing
Jin, Hui
Yang, Nailong
Shi, Xiaoyun
Li, Quanmin
Liang, Linlang
Zang, Li
Liu, Mingming
He, James
Mu, Yiming
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-2267-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes-A Real-World Study (China PDS)
    Han, Ying
    Chen, Lixian
    Hu, Daqing
    Jin, Hui
    Yang, Nailong
    Shi, Xiaoyun
    Li, Quanmin
    Liang, Linlang
    Zang, Li
    Liu, Mingming
    He, James
    Mu, Yiming
    DIABETES, 2018, 67
  • [2] Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Agents in Different Regional Patients with Type 2 Diabetes-A Real-World Study (China PDS)
    Zang, Li
    Han, Ying
    Chen, Lixian
    Hu, Daqing
    Jin, Hui
    Yang, Nailong
    Shi, Xiaoyun
    Li, Quanmin
    Liang, Linlang
    Liu, Mingming
    He, James
    Mu, Yiming
    DIABETES, 2018, 67
  • [3] Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Antidiabetes Agents in Different Baseline BMI Patients with Type 2 Diabetes-A Real-World Study (China PDS)
    Jin, Hui
    Han, Ying
    Chen, Lixian
    Hu, Daqing
    Yang, Nailong
    Shi, Xiaoyun
    Li, Quanmin
    Liang, Linlang
    Zang, Li
    Liu, Mingming
    He, James
    Mu, Yiming
    DIABETES, 2018, 67
  • [4] Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Antidiabetes Agents in Different Baseline HbA1c Patients with Type 2 Diabetes-A Real-World Study (China PDS)
    Hu, Daqing
    Han, Ying
    Chen, Lixian
    Jin, Hui
    Yang, Nailong
    Shi, Xiaoyun
    Li, Quanmin
    Liang, Linlang
    Zang, Li
    Liu, Mingming
    He, James
    Mu, Yiming
    DIABETES, 2018, 67
  • [5] Efficacy and Safety of Vildagliptin plus Metformin Compared with Other Oral Agents Dual Therapy in Patients with Type 2 Diabetes: China PDS Interim Results
    Zang, Li
    Han, Yin
    Liu, Yan
    Hu, Daqing
    Chen, Lixian
    Yang, Nailong
    Jin, Hui
    Shi, Xiaoyun
    Li, Quanming
    Lang, Linliang
    Ji, Fengping
    Wang, Binhui
    He, James
    Mu, Yi Ming
    DIABETES, 2017, 66 : A316 - A316
  • [6] Effectiveness, safety, and tolerability of vildagliptin or vildagliptin/metformin combination in patients with type 2 diabetes uncontrolled on insulin therapy in a real-world setting in Egypt: The OMEGA study
    El Ebrashy, Ibrahim
    El Kafrawy, Nabil
    Raouf, Rana
    Yousry, Diana
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 162
  • [7] THE LONG-TERM COST-EFFECTIVENESS OF VILDAGLIPTIN plus METFORMIN THERAPY RELATIVE TO COMPARATOR SULFONYLUREA plus METFORMIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
    Xu, J.
    VALUE IN HEALTH, 2020, 23 : S131 - S131
  • [8] Vildagliptin efficacy and safety in patients with type 2 diabetes inadequately controlled on dual metformin plus sulfonylurea therapy
    Lukashevich, V.
    Wang, M.
    Del Prato, S.
    Araga, M.
    Kothny, W.
    DIABETOLOGIA, 2012, 55 : S353 - S353
  • [9] Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus
    Guarino, Elisa
    Nigi, Laura
    Patti, Aurora
    Fondelli, Cecilia
    Dotta, Francesco
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (09) : 1377 - 1384
  • [10] Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy
    Inzucchi, S. E.
    Tunceli, K.
    Qiu, Y.
    Rajpathak, S.
    Brodovicz, K. G.
    Engel, S. S.
    Mavros, P.
    Radican, L.
    Brudi, P.
    Li, Z.
    Fan, C. P. S.
    Hanna, B.
    Tang, J.
    Blonde, L.
    DIABETES OBESITY & METABOLISM, 2015, 17 (10): : 956 - 964
12345